3d-human-tissue-models | Media Room

Press Release Sep 3, 2024

Humonix Bio Announces Appointment of Thurein Htoo as Chairman of the Board of Directors and Welcomes Christie Markowitz as New Independent Board Director

Press Release May 2, 2024

Humonix Biosciences Appoints Karen Torrejon, PhD, as New Chief Executive Officer

Dr. Torrejon, the original founder of Humonix, replaces Kimberly Southern

Press Release Sep 26, 2023

Humonix Biosciences Launches New 3D Human Tissue Model

Specialty pharmaceutical research company’s new retinal vascular dysfunction model can have a major impact on research and development of new drugs for retinal vascular diseases.

Press Release Jul 11, 2023

Glauconix is Now Humonix

Specialty pharmaceutical research company celebrates the launch of a new service offering and with it, a brand refresh.

Press Release Apr 27, 2021

Glauconix Data Published in Prestigious Ophthalmology Journal as Part of Their Work With NCX 667, a Novel Nitric Oxide Donor Agent With Intraocular Pressure Lowering Ability

The in-vitro studies performed in Glauconix's co-culture 3D conventional human outflow model confirm efficacy

Press Release Mar 23, 2021

Glauconix Biosciences Awarded National Science Foundation Phase IIB Small Business Innovation Research Grant

3D Human Tissue Retina Vasculature model provides a new and novel approach to rapidly and efficiently screening numerous therapies for diabetic retinopathy and diabetic macular edema.

Press Release Mar 2, 2021

Glauconix Biosciences Expands Scientific Advisory Board for 3D Human Tissue Retina Vasculature Model With the Addition of Leading Expert Dr. Patricia D'Amore

Appointment reflects Glauconix Biosciences' expansion of their 3D Human Tissue model platform within the Ophthalmology space and brings their second commercial model closer to market